GL1X · GenesisL1 explorer

Research workbench

Dabigatran reversal agent

Analyse Dabigatran reversal agent in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4YHN
Type
protein
Length
876 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Adabi-FAB3 heavy chain; Adabi-FAB3 light chain
Pockets
9 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, FAdabi-FAB3 heavy chainprotein2208% helix, 50% strand—
B, LAdabi-FAB3 light chainprotein2186% helix, 50% strand—

Pockets

9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17020.660.7564empty
25820.620.7461empty
32930.580.7735empty
41630.530.8031empty
5590.310.7615empty

Interfaces

4 interfaces between chains.

  • A–B · 1923 Ų buried · 16 hydrogen bonds · protein-protein
  • F–L · 1923 Ų buried · 13 hydrogen bonds · protein-protein
  • A–F · 396 Ų buried · 7 hydrogen bonds · protein-protein
  • B–F · 129 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 4YHN · Dabigatran Reversal Agent · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.